FindTrial
Sign In

Clinical efficacy of ulinastatin in the perioperative period of cardiopulmonary bypass in cardiac surgery: a retrospective real-world study

Clinical efficacy of ulinastatin in the perioperative period of cardiopulmonary bypass in cardiac surgery: a retrospective real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089064
Enrollment
Unknown
Registered
2024-08-30
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing cardiac surgery with cardiopulmonary bypass

Interventions

Case series:NA

Sponsors

Beijing Anzhen Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing cardiac surgery with cardiopulmonary bypass (including coronary artery bypass grafting, valve repair or replacement, or repair of congenital heart malformation, large vessel, aortic disease); 2. Patients who underwent surgery between January 1, 2018 and December 31, 2023; 3. Standard-of-care patients with or without ulinastatin

Exclusion criteria

Exclusion criteria: 1. Patients with severe subarachnoid hemorrhage; 2. Patients with multiple extracorporeal circulation operations; 3.Incomplete records (missing information on patient ID, age, sex, and diagnosis).

Design outcomes

Primary

MeasureTime frame
All-cause mortality;—

Secondary

MeasureTime frame
Cardiopulmonary bypass time;Duration of mechanical ventilation;—

Countries

China

Contacts

Public ContactHou Xiaotong

Beijing Anzhen Hospital Affiliated to Capital Medical University

xt.hou@ccmu.edu.cn+86 189 1166 2932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026